CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in CNS Pharmaceuticals, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- No complete 13F data for Q4 2020
- Shares held
- 1.27M
- No complete 13F data for Q4 2020
- Total value
- $3.04M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting CNSP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $1.34M |
| Q1 2026 | 12 | $348.7K |
| Q4 2025 | 10 | $652.4K |
| Q3 2025 | 8 | $221.5K |
| Q2 2025 | 11 | $421.8K |
| Q1 2025 | 7 | $55.2K |
| Q4 2024 | 21 | $297.3K |
| Q3 2024 | 14 | $75.3K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 19 | $351.0K |
| Q4 2023 | 16 | $425.3K |
| Q3 2023 | 12 | $131.7K |
| Q2 2023 | 12 | $234.4K |
| Q1 2023 | 13 | $190.5K |
| Q4 2022 | 10 | $335.0K |
| Q3 2022 | 21 | $232.0K |
| Q2 2022 | 23 | $343.5K |
| Q1 2022 | 20 | $589.0K |
| Q4 2021 | 24 | $828.0K |
| Q3 2021 | 20 | $1.44M |
| Q2 2021 | 20 | $2.64M |
| Q1 2021 | 19 | $3.04M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding CNS Pharmaceuticals, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 722,760 | $1.73M | 0.00% | – | – |
| Vanguard Group Inc | 140,491 | $336.0K | 0.00% | – | – |
| Citadel Advisors LLC | 92,404 | $221.0K | 0.00% | – | – |
| Geode Capital Management, LLC | 60,784 | $145.0K | 0.00% | – | – |
| Essex Investment Management Co LLC | 59,565 | $142.0K | 0.02% | – | – |
| Bank of New York Mellon Corp | 43,659 | $104.0K | 0.00% | – | – |
| Virtu Financial LLC | 41,310 | $99.0K | 0.01% | – | – |
| Northern Trust Corp | 32,094 | $77.0K | 0.00% | – | – |
| Wells Fargo & Company | 13,850 | $33.0K | 0.00% | – | – |
| Jane Street Group, LLC | 13,747 | $33.0K | 0.00% | – | – |
| Morgan Stanley | 12,500 | $30.0K | 0.00% | – | – |
| Goldman Sachs Group Inc | 11,566 | $28.0K | 0.00% | – | – |
| Alpha Cubed Investments, LLC | 11,000 | $26.0K | 0.00% | – | – |
| Integrated Advisors Network LLC | 10,700 | $26.0K | 0.00% | – | – |
| Advisor Group Holdings, Inc. | 5,000 | $12.0K | 0.00% | – | – |
| UBS Group AG | 1,360 | $3.00K | 0.00% | – | – |
| Capital Analysts, LLC | 1,000 | $2.00K | 0.00% | – | – |
| Gradient Investments LLC | 200 | $0 | 0.00% | – | – |
| Sowell Financial Services LLC | 100 | $0 | 0.00% | – | – |